The recent development of oral interferon (IFN)-free direct-acting antiviral agents (DAAs) has important implications for managing hepatitis C virus (HCV) in patients with rheumatic symptoms. Patients may have preexisting rheumatic disorders at the time of HCV infection or may develop an HCV-related autoimmune disorder that manifests rheumatic symptoms.1
Most HCV-related extrahepatic manifestations are autoimmune or inflammatory disorders that commonly cause rheumatic symptoms. A high prevalence of patients with HCV experience rheumatic symptoms as the disease progresses. Between 6% and 20% develop arthralgia, which typically arises symmetrically in joints of the knees, back, and fingers; arthralgia of the ankles or elbows is rare.1 Myalgia is less common, affecting 2% to 5% of patients.1Continue reading....
Navigate This Blog
Extrahepatic manifestations of HCV & Treatment
Rheumatologic manifestations of hepatitis C virus - is included in this collection of articles.
All Articles
A collection of research articles on ailments related to HCV
Categorized article directory on the extrahepatic manifestations of hepatitis C.
No comments:
Post a Comment